SEC Info - Biotechnology Value Fund LP - ‘SC 13G’ on 9/29/22 re: Allakos Inc.

SEC Info℠

Home

Help

Please Sign In

Biotechnology Value Fund LP – ‘SC 13G’ on 9/29/22 re: Allakos Inc. – ‘EX-99.1’

On: Thursday, 9/29/22, at 4:28pm ET · Accession #: 921895-22-2724 · File #: 5-90578

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/29/22  Biotechnology Value Fund LP       SC 13G                 2:271K Allakos Inc.                      Olshan Frome Wolosky LLP

Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G — WA’68

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G      The Schedule 13G                                    HTML    262K 
 2: EX-99.1     Joint Filing Agreement                              HTML      9K

‘EX-99.1’ — Joint Filing Agreement

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 99.1

Joint Filing Agreement

The undersigned hereby agree that the Statement on Schedule 13G dated September 29, 2022 with respect to the Common Stock, par value $0.001 per share, of Allakos Inc., a Delaware corporation, and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

Dated: September 29, 2022

BIOTECHNOLOGY VALUE FUND, L.P.		BIOTECHNOLOGY VALUE TRADING FUND OS LP

By:	BVF I GP LLC., its general partner	By:	BVF Partners L.P., its investment manager
		By:	BVF Inc., its general partner
By:	/s/ *Mark N. Lampert*
	Mark N. Lampert	By:	/s/ *Mark N. Lampert*
	Chief Executive Officer		Mark N. Lampert
			President

BVF I GP LLC
		BVF GP HOLDINGS LLC
By:	/s/ *Mark N. Lampert*
	Mark N. Lampert	By:	/s/ *Mark N. Lampert*
	Chief Executive Officer		Mark N. Lampert
			Chief Executive Officer

BIOTECHNOLOGY VALUE FUND II, L.P.
		BVF PARTNERS L.P.
By:	BVF II GP LLC, its general partner
		By:	BVF Inc., its general partner
By:	/s/ *Mark N. Lampert*
	Mark N. Lampert	By:	/s/ *Mark N. Lampert*
	Chief Executive Officer		Mark N. Lampert
			President

BVF II GP LLC
		BVF INC.
By:	/s/ *Mark N. Lampert*
	Mark N. Lampert	By:	/s/ *Mark N. Lampert*
	Chief Executive Officer		Mark N. Lampert
			President

BVF PARTNERS OS LTD.
		/s/ *Mark N. Lampert*
By:	BVF Partners L.P., its sole member	MARK N. LAMPERT
By:	BVF Inc., its general partner

By:	/s/ *Mark N. Lampert*
	Mark N. Lampert
	President

Dates Referenced Herein

This ‘SC 13G’ Filing	Date	Other Filings

Filed on:	9/29/22	None on these Dates
		List all Filings

↑Top

Filing Submission 0000921895-22-002724 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)